DE60043229D1 - Zusammensetzung zur gefässbeschichtung - Google Patents
Zusammensetzung zur gefässbeschichtungInfo
- Publication number
- DE60043229D1 DE60043229D1 DE60043229T DE60043229T DE60043229D1 DE 60043229 D1 DE60043229 D1 DE 60043229D1 DE 60043229 T DE60043229 T DE 60043229T DE 60043229 T DE60043229 T DE 60043229T DE 60043229 D1 DE60043229 D1 DE 60043229D1
- Authority
- DE
- Germany
- Prior art keywords
- composition
- vessel coating
- coating
- vessel
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/92—Method or apparatus for preparing or treating prosthetic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/92—Method or apparatus for preparing or treating prosthetic
- Y10S623/921—Blood vessel
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15395099P | 1999-09-15 | 1999-09-15 | |
PCT/US2000/025310 WO2001019347A1 (en) | 1999-09-15 | 2000-09-15 | Vascular coating composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60043229D1 true DE60043229D1 (de) | 2009-12-10 |
Family
ID=22549391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60043229T Expired - Lifetime DE60043229D1 (de) | 1999-09-15 | 2000-09-15 | Zusammensetzung zur gefässbeschichtung |
Country Status (10)
Country | Link |
---|---|
US (2) | US6372229B1 (de) |
EP (1) | EP1214057B1 (de) |
JP (1) | JP2003509362A (de) |
AT (1) | ATE446776T1 (de) |
AU (1) | AU769136B2 (de) |
CA (1) | CA2385150C (de) |
DE (1) | DE60043229D1 (de) |
HK (1) | HK1047404B (de) |
NO (1) | NO20021281L (de) |
WO (1) | WO2001019347A1 (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019347A1 (en) * | 1999-09-15 | 2001-03-22 | Cryolife, Inc. | Vascular coating composition |
US20040018228A1 (en) * | 2000-11-06 | 2004-01-29 | Afmedica, Inc. | Compositions and methods for reducing scar tissue formation |
CA2494295C (en) | 2002-08-06 | 2012-05-01 | Matrix Medical, Llc | Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
US10098981B2 (en) | 2002-08-06 | 2018-10-16 | Baxter International Inc. | Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
US8349348B2 (en) * | 2002-08-06 | 2013-01-08 | Matrix Medical, Llc | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
US9101536B2 (en) * | 2002-08-06 | 2015-08-11 | Matrix Medical Llc | Biocompatible phase invertable proteinaceous compositions and methods for making and using the same |
DE10236152A1 (de) * | 2002-08-07 | 2004-02-19 | Marker Deutschland Gmbh | Ski- und Skibindungs-Kombination |
US7803150B2 (en) * | 2004-04-21 | 2010-09-28 | Acclarent, Inc. | Devices, systems and methods useable for treating sinusitis |
US7670282B2 (en) | 2004-06-14 | 2010-03-02 | Pneumrx, Inc. | Lung access device |
US20060004400A1 (en) * | 2004-06-16 | 2006-01-05 | Mcgurk Erin | Method of treating a lung |
US20050281739A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue using compositions |
US20050281740A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
US7678767B2 (en) | 2004-06-16 | 2010-03-16 | Pneumrx, Inc. | Glue compositions for lung volume reduction |
US7608579B2 (en) * | 2004-06-16 | 2009-10-27 | Pneumrx, Inc. | Lung volume reduction using glue compositions |
US7553810B2 (en) * | 2004-06-16 | 2009-06-30 | Pneumrx, Inc. | Lung volume reduction using glue composition |
US20050281799A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting damaged lung tissue using compositions |
US20050281798A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting sites of damaged lung tissue using composition |
WO2006014567A2 (en) * | 2004-07-08 | 2006-02-09 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
EP1816945B1 (de) | 2004-11-23 | 2019-08-21 | PneumRx, Inc. | Steuerbare vorrichtung zum ansteuern eines zielortes |
US20070014830A1 (en) * | 2005-06-08 | 2007-01-18 | Tijsma Edze J | Drug-releasing sinus stent |
US20070110788A1 (en) * | 2005-11-14 | 2007-05-17 | Hissong James B | Injectable formulation capable of forming a drug-releasing device |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US7976873B2 (en) * | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
US7959943B2 (en) * | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
US7993675B2 (en) * | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
AU2007294808A1 (en) * | 2006-09-13 | 2008-03-20 | Southeastern Medical Technologies, Llc | Methods and compositions for sealing and adhering biological tissues and medical uses thereof |
US20100297218A1 (en) * | 2006-09-20 | 2010-11-25 | Pneumrx, Inc. | Tissue adhesive compositions and methods thereof |
US8088095B2 (en) * | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
US20090011043A1 (en) * | 2007-07-03 | 2009-01-08 | Hua Xie | Tissue sealant made from whole blood |
EP2219555B9 (de) | 2007-12-03 | 2015-12-23 | Tenaxis Medical, Inc. | Biokompatible phasen-umkehrbare proteinöse zusammensetzungen |
CA2727432C (en) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Method for treating chronic wounds with an extracellular polymeric substance solvating system |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US9155815B2 (en) * | 2009-04-17 | 2015-10-13 | Tenaxis Medical, Inc. | Biocompatible phase invertible proteinaceous compositions and methods for making and using the same |
CN104622599B (zh) | 2009-05-18 | 2017-04-12 | 纽姆克斯股份有限公司 | 细长的肺减容装置在部署过程中的横截面变化 |
US20110077216A1 (en) * | 2009-09-30 | 2011-03-31 | Massachusetts Institute Of Technology | Compositions and methods for the treatment of atherosclerosis and other related diseases |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
WO2019231763A1 (en) | 2018-05-27 | 2019-12-05 | Christos Angeletakis | Tissue adhesives and sealants using naturally derived aldehydes |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4247406A (en) * | 1979-04-23 | 1981-01-27 | Widder Kenneth J | Intravascularly-administrable, magnetically-localizable biodegradable carrier |
US4979959A (en) | 1986-10-17 | 1990-12-25 | Bio-Metric Systems, Inc. | Biocompatible coating for solid surfaces |
US5213580A (en) * | 1988-08-24 | 1993-05-25 | Endoluminal Therapeutics, Inc. | Biodegradable polymeric endoluminal sealing process |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
JP2836878B2 (ja) * | 1988-08-24 | 1998-12-14 | スリピアン,マービン,ジェイ | 生分解性高分子材料による管腔内封止 |
US5654267A (en) | 1988-12-20 | 1997-08-05 | La Jolla Cancer Research Center | Cooperative combinations of ligands contained within a matrix |
CA2070149A1 (en) * | 1991-06-04 | 1992-12-05 | Stephen J. Boccuzzi | Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty |
US5385606A (en) * | 1992-07-06 | 1995-01-31 | Kowanko; Nicholas | Adhesive composition and method |
US5914345A (en) * | 1994-10-11 | 1999-06-22 | Endoluminal Therapeutics, Inc. | Treatment of tissues to reduce subsequent response to injury |
US5900245A (en) * | 1996-03-22 | 1999-05-04 | Focal, Inc. | Compliant tissue sealants |
WO2001019347A1 (en) * | 1999-09-15 | 2001-03-22 | Cryolife, Inc. | Vascular coating composition |
-
2000
- 2000-09-15 WO PCT/US2000/025310 patent/WO2001019347A1/en active IP Right Grant
- 2000-09-15 DE DE60043229T patent/DE60043229D1/de not_active Expired - Lifetime
- 2000-09-15 AU AU73811/00A patent/AU769136B2/en not_active Ceased
- 2000-09-15 AT AT00961923T patent/ATE446776T1/de not_active IP Right Cessation
- 2000-09-15 US US09/662,459 patent/US6372229B1/en not_active Expired - Lifetime
- 2000-09-15 CA CA2385150A patent/CA2385150C/en not_active Expired - Fee Related
- 2000-09-15 JP JP2001522982A patent/JP2003509362A/ja active Pending
- 2000-09-15 EP EP00961923A patent/EP1214057B1/de not_active Expired - Lifetime
-
2002
- 2002-02-07 US US10/067,331 patent/US6849262B2/en not_active Expired - Fee Related
- 2002-03-14 NO NO20021281A patent/NO20021281L/no not_active Application Discontinuation
- 2002-12-12 HK HK02109028.5A patent/HK1047404B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1214057A1 (de) | 2002-06-19 |
NO20021281L (no) | 2002-03-26 |
CA2385150A1 (en) | 2001-03-22 |
US6849262B2 (en) | 2005-02-01 |
WO2001019347A1 (en) | 2001-03-22 |
JP2003509362A (ja) | 2003-03-11 |
ATE446776T1 (de) | 2009-11-15 |
US20020183244A1 (en) | 2002-12-05 |
EP1214057B1 (de) | 2009-10-28 |
EP1214057A4 (de) | 2006-03-29 |
CA2385150C (en) | 2010-11-23 |
HK1047404B (zh) | 2010-05-20 |
AU7381100A (en) | 2001-04-17 |
NO20021281D0 (no) | 2002-03-14 |
US6372229B1 (en) | 2002-04-16 |
HK1047404A1 (en) | 2003-02-21 |
AU769136B2 (en) | 2004-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE446776T1 (de) | Zusammensetzung zur gefässbeschichtung | |
ATE382681T1 (de) | Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen | |
MXPA04001334A (es) | Materiales y metodos para promover la reparacion de tejido nervioso. | |
WO2001088103A3 (en) | Compositions and methods for tissue dedifferentiation and regeneration | |
ATE305788T1 (de) | (s,s)-reboxetin zur behandlung von inkontinenz | |
WO2003080801A3 (en) | Adipose stromal stem cells for tissue and vascular modification | |
DE69941566D1 (de) | N-acetylhomotaurinate zur verwendung in der behandlung von hyperkinesie | |
WO2003087303A3 (en) | Tissue composites and uses thereof | |
ATE404228T1 (de) | Implantat mit einer keramischen beschichtung | |
DE60013098D1 (de) | Zusammensetzung zur hautdesinfizierung | |
ATE448811T1 (de) | Verfahren zur verbesserung der anhaftung von weichteilgewebe und implantate, die gebrauch von diesem verfahen machen | |
DE60043832D1 (de) | Zusammensetzung zur Hydrophobierung von Gips, Verfahren zur Herstellung und Anwendung | |
ATE296123T1 (de) | Verfahren zur herstellung bioaktiver implantatoberflächen | |
TR199802441A3 (tr) | Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip. | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DE69937679D1 (de) | Wasserlösliche zusammensetzung enthaltend aktive inhaltsstoffe zur depigmentierung der haut | |
DE60002003D1 (de) | Verfahren zur Herstellung von Silikon-Polyether-Copolymeren mit vermindertem Geruch | |
TW200517134A (en) | Hydrophobic tooth whitening system and methods of use | |
BR0014560B1 (pt) | uso de uma composiÇço de tratamento de tecidos. | |
DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
DK1021519T3 (da) | Fremgangsmåde til rengøring af kirurgiske instrumenter | |
AU2001272622A1 (en) | Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair | |
DE69901243D1 (de) | Artikulator zur herstellung von zahnärztlichen prothesen | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
DE59805246D1 (de) | Tissue-faktor zur beeinflussung von gefässbildung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |